Clinical trial
The Characteristics of Sequence Effect in de Novo and Advanced Parkinson's Disease
NCT00431366 is registered in ClinicalTrials.gov with National Institute of Neurological Disorders and Stroke (NINDS) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Characteristics of Sequence Effect in de Novo and Advanced Parkinson's Disease
- Lead sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 1, 2007
- Completion date
- December 24, 2008
- Enrollment
- 24
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease